Presented at San Antonio Breast Cancer Symposium (SABCS); December 8 ... Pictured: Eli Lilly's biotechnology center in San Diego, California.
News
- Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence ... - BioSpace
- bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering ...
SAN ANTONIO--(BUSINESS WIRE)--Oct 18, 2024--. bioAffinity Technologies, Inc.(Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for ...
- bioAffinity Technologies Prices of $2.66 Million Registered Direct Offering & Concurrent ...
Dallas, Houston Biotech / Medtech ... SAN ANTONIO–(BUSINESS WIRE)–bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology ...
- bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering ...
SAN ANTONIO --(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive ...
- Director Wu Yue Alexander bought $18,992 worth of shares (20,000 units at $0.95 ... - Quantisnow
960 SAN ANTONIO ROAD. (Street). PALO ALTO, CA ... Biotechnology: Biological Products (No Diagnostic Substances). Health Care ... Health Care. SEC ...